SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-012006
Filing Date
2021-06-10
Accepted
2021-06-10 16:08:07
Documents
14
Period of Report
2021-06-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K auph-20210607.htm   iXBRL 8-K 78549
2 EX-99.1 a9912021auriniaamendedandr.htm EX-99.1 119519
3 EX-99.2 a992employeesharepurchasep.htm EX-99.2 91241
  Complete submission text file 0001628280-21-012006.txt   473695

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT auph-20210607.xsd EX-101.SCH 1942
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT auph-20210607_lab.xml EX-101.LAB 23970
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT auph-20210607_pre.xml EX-101.PRE 12668
7 EXTRACTED XBRL INSTANCE DOCUMENT auph-20210607_htm.xml XML 11099
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36421 | Film No.: 211008134
SIC: 2834 Pharmaceutical Preparations